SpectraCell is a precision laboratory that measures functional health at the cellular level. Key areas of focus include:
- Cellular Nutrition
- Cardiovascular Health
- Genetic Predisposition
The core tests we work with are the micronutrient test and the lipoprotein particle test.
Micronutrient Test (MNT)
SpectraCell’s Micronutrient Test (MNT) is the leading scientific and objective assessment of functional intracellular micronutrient status. This test provides the most comprehensive nutritional analysis available and measures functional deficiencies at the cellular level, assessing how the body utilises 31 vitamins, minerals, amino and fatty acids, antioxidants, and metabolites, while conveying the body’s need for these micronutrients that enable the body to produce enzymes, hormones, and everything else the body needs for proper growth, development, and good health.
The personalised and targeted approach: This test is unique because it measures the functional level and capability of micronutrients present within white blood cells, where metabolism takes place and where micronutrients do their job.
Unlike static serum measurements which only assess the concentration of nutrients present outside of the cell and only provide a glimpse of your health, SpectraCell’s Micronutrient test is a long term assessment (4-6 months) that addresses the functional impact of micronutrients.
Nutrient status is crucial for all metabolic and development processes that take place within the body. Deficiencies can contribute to chronic diseases and degenerative processes scubas dementia, cardiovascular disease, diabetes, cancer and arthritis and optimising nutrient status is of the highest priority for patient outcome.
Examples of Clinical Applications:
- Cardiovascular disease
- Neurological disorders: Alzheimer’s disease and other cognitive decline diagnoses
- Autism and other spectrum disorders
- Mood disorders
- Fertility issues and hormone imbalances
- Weight issues
- Optimisation of sports performance
Lipoprotein Particle Profile (LPP)
Cholesterol has historically been used as the standard indicator for cardiovascular disease, often being classified as “good” (HDL) or “bad” (LDL). We now know this does not give us the complete picture.
Studies have found that it is the lipoprotein particles that carry the cholesterol throughout the blood, and not the cholesterol within them that are responsible for key steps in plaque formation and the pathogenesis of cardiovascular disease.
The small, dense, cholesterol-depleted particles impart the highest risk, as does a higher number of these lipoproteins. Standard cholesterol testing does not tell us enough about the particle types or subgroups of each of these LDL and HDL families; therefore testing early can mitigate future problems.
Cardiovascular risk increases with a higher LDL particle count. With a higher non-HDL count, the probability of particle penetration of the arterial walls rises, regardless of the total amount of cholesterol contained in each particle.
More than 30% of the population has cholesterol-depleted LDL, a condition in which a patient’s cholesterol may be “normal” but their lipoprotein particle number, and hence their actual risk, could be much higher than expected. This is especially common where triglycerides are high or HDL is low.
Telomeres are sections of genetic material that form a protective cap at the end of each chromosome in every cell of the body. When a cell divides, the telomere gets slightly shorter, until there is no more telomere left to protect DNA from “unravelling,” at which point the cell dies.
Cellular death causes the body to age, thus making telomeres a useful and novel biomarker for assessing biological age. The longer one’s telomeres, the younger one’s biological age. Moreover, the rate at which telomeres shorten is accelerated by inflammation, oxidative stress, nutritional deficiencies, genetic predisposition, and other lifestyle habits such as smoking, recreational drug use, alcohol use and exposure to toxic chemicals and moulds. Telomere shortening, when expedited, contributes to cardiovascular disease and stroke, mood disorders such as depression and anxiety, dementia, diabetes and cancers.